In this multi-institutional study, due to the rarity of these tumours we hereby report a case series (four cases) of head and neck RMS in adults harbouring TFCP2 mutations along with diagnostic, therapeutic and prognostic details. This evidence concerns the gene TFCP2 and neoplasm.